Vaxcyte Launches $1 Billion Offerings of Stock, Prefunded Warrants, 2032 Notes
MT newswire2026/10/05 21:0705:07 PM EDT, 10/05/2026 (MT Newswires) -- Vaxcyte (PCVX) launched underwritten offerings of $500 million of its common stock and prefunded warrants and $500 million of convertible senior notes due 2032, the company said Monday. The company intends to grant underwriters 30-day overallotment options to buy up to an additional $75 million of common stock and $75 million of notes. Net proceeds will be used to fund clinical development of Vaxcyte's pneumococcal vaccine programs, including VAX-31, manufacturing expansion, research and development, and general corporate purposes, the company said. Vaxcyte shares fell 3.4% in after-hours trading.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rumor: Tesla (TSLA.US) and SpaceX (SPCX.US) plan Terafab monthly production of one million wafers, feasibility questioned
According to reports, Tesla (TSLA.US) and SpaceX (SPCX.US) plan to achieve a production capacity of 1 million semiconductor wafers per month at the proposed Terafab factory starting in 2032.
Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Crypto prices
More
